Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Soluble Epoxide Hydrolase Inhibitor and 14,15-Epoxyeicosatrienoic Acid-Facilitated Long-Term Potentiation through cAMP and CaMKII in the Hippocampus.

Wu HF, Chen YJ, Wu SZ, Lee CW, Chen IT, Lee YC, Huang CC, Hsing CH, Tang CW, Lin HC.

Neural Plast. 2017;2017:3467805. doi: 10.1155/2017/3467805. Epub 2017 Aug 24.

2.

The Role of BiP Retrieval by the KDEL Receptor in the Early Secretory Pathway and its Effect on Protein Quality Control and Neurodegeneration.

Jin H, Komita M, Aoe T.

Front Mol Neurosci. 2017 Jul 17;10:222. doi: 10.3389/fnmol.2017.00222. eCollection 2017. Review.

3.
4.

Functional Roles of the Interaction of APP and Lipoprotein Receptors.

Pohlkamp T, Wasser CR, Herz J.

Front Mol Neurosci. 2017 Mar 1;10:54. doi: 10.3389/fnmol.2017.00054. eCollection 2017. Review.

5.

The ApoE receptors Vldlr and Apoer2 in central nervous system function and disease.

Lane-Donovan C, Herz J.

J Lipid Res. 2017 Jun;58(6):1036-1043. doi: 10.1194/jlr.R075507. Epub 2017 Mar 14. Review.

PMID:
28292942
6.

ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease.

Lane-Donovan C, Herz J.

Trends Endocrinol Metab. 2017 Apr;28(4):273-284. doi: 10.1016/j.tem.2016.12.001. Epub 2017 Jan 2. Review.

PMID:
28057414
7.

Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses.

Wasser CR, Herz J.

J Biol Chem. 2017 Jan 27;292(4):1330-1338. doi: 10.1074/jbc.R116.766782. Epub 2016 Dec 19. Review.

8.
9.

The β-amyloid peptide compromises Reelin signaling in Alzheimer's disease.

Cuchillo-Ibañez I, Mata-Balaguer T, Balmaceda V, Arranz JJ, Nimpf J, Sáez-Valero J.

Sci Rep. 2016 Aug 17;6:31646. doi: 10.1038/srep31646.

10.

Canonical and Non-canonical Reelin Signaling.

Bock HH, May P.

Front Cell Neurosci. 2016 Jun 30;10:166. doi: 10.3389/fncel.2016.00166. eCollection 2016. Review.

11.

New Insights into Reelin-Mediated Signaling Pathways.

Lee GH, D'Arcangelo G.

Front Cell Neurosci. 2016 May 9;10:122. doi: 10.3389/fncel.2016.00122. eCollection 2016. Review.

12.

Reelin Proteolysis Affects Signaling Related to Normal Synapse Function and Neurodegeneration.

Lussier AL, Weeber EJ, Rebeck GW.

Front Cell Neurosci. 2016 Mar 29;10:75. doi: 10.3389/fncel.2016.00075. eCollection 2016. Review.

13.

Loss of Reelin protects against atherosclerosis by reducing leukocyte-endothelial cell adhesion and lesion macrophage accumulation.

Ding Y, Huang L, Xian X, Yuhanna IS, Wasser CR, Frotscher M, Mineo C, Shaul PW, Herz J.

Sci Signal. 2016 Mar 15;9(419):ra29. doi: 10.1126/scisignal.aad5578.

14.

Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides.

Hinrich AJ, Jodelka FM, Chang JL, Brutman D, Bruno AM, Briggs CA, James BD, Stutzmann GE, Bennett DA, Miller SA, Rigo F, Marr RA, Hastings ML.

EMBO Mol Med. 2016 Apr 1;8(4):328-45. doi: 10.15252/emmm.201505846.

15.

Neonatal seizures alter NMDA glutamate receptor GluN2A and 3A subunit expression and function in hippocampal CA1 neurons.

Zhou C, Sun H, Klein PM, Jensen FE.

Front Cell Neurosci. 2015 Sep 23;9:362. doi: 10.3389/fncel.2015.00362. eCollection 2015.

16.

Reelin protects against amyloid β toxicity in vivo.

Lane-Donovan C, Philips GT, Wasser CR, Durakoglugil MS, Masiulis I, Upadhaya A, Pohlkamp T, Coskun C, Kotti T, Steller L, Hammer RE, Frotscher M, Bock HH, Herz J.

Sci Signal. 2015 Jul 7;8(384):ra67. doi: 10.1126/scisignal.aaa6674.

17.

APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.

Liu DS, Pan XD, Zhang J, Shen H, Collins NC, Cole AM, Koster KP, Ben Aissa M, Dai XM, Zhou M, Tai LM, Zhu YG, LaDu M, Chen XC.

Mol Neurodegener. 2015 Mar 5;10:7. doi: 10.1186/s13024-015-0002-2.

18.

Lrp4 domains differentially regulate limb/brain development and synaptic plasticity.

Pohlkamp T, Durakoglugil M, Lane-Donovan C, Xian X, Johnson EB, Hammer RE, Herz J.

PLoS One. 2015 Feb 17;10(2):e0116701. doi: 10.1371/journal.pone.0116701. eCollection 2015.

19.

Linking hypothetical knowledge patterns to disease molecular signatures for biomarker discovery in Alzheimer's disease.

Malhotra A, Younesi E, Bagewadi S, Hofmann-Apitius M.

Genome Med. 2014 Dec 3;6(11):97. doi: 10.1186/s13073-014-0097-z. eCollection 2014.

20.

Differential splicing and glycosylation of Apoer2 alters synaptic plasticity and fear learning.

Wasser CR, Masiulis I, Durakoglugil MS, Lane-Donovan C, Xian X, Beffert U, Agarwala A, Hammer RE, Herz J.

Sci Signal. 2014 Nov 25;7(353):ra113. doi: 10.1126/scisignal.2005438.

Supplemental Content

Support Center